Van Lanschot Kempen Logo
Search
Van Lanschot Kempen Logo
Search

Q1 2025 (pending)
transaction logo image
Sole Financial Adviser
€508 million
Buy-side M&A
Right Arrow in Circle
Pending
Pharming logo
Sole Financial Adviser
SEK 725 million
Recommended cash offer to acquire Abliva
Right Arrow in Circle
January 2025 (pending)
vastned
Sole Financial Adviser
€1.3 billion
Reverse merger with Vastned Belgium
Right Arrow in Circle
December 2024
transaction logo image
Financial Adviser to the Company
USD 479 million
US Public Offering
Right Arrow in Circle
December 2024
transaction logo image
Sole Financial Adviser
€20 million
Venture debt financing

Right Arrow in Circle
November 2024
transaction logo image
Sell-side public M&A
€219 million
62.78% stake in
Right Arrow in Circle
October 2024
montea Logo
Joint Global Coordinator & Joint Bookrunner
€ 154 million
Rights Issue
Right Arrow in Circle
September 2024
Amvest
Financial Adviser
€300 million
Inaugural Green Bond
Right Arrow in Circle
September 2024
transaction logo image
Joint Global Coordinator & Joint Bookrunner
SEK 1.1 billion
Accelerated Bookbuild Offering
Right Arrow in Circle
August 2024
Amvest
Financial Adviser
Baa2, Outlook Positive
First Time Rating Issuer Moody’s
Right Arrow in Circle
August 2024
catena
Joint Global Coordinator & Joint Bookrunner
SEK 3.1 billion
Accelerated Bookbuild Offering
Right Arrow in Circle
July 2024
Amvest
Sole Financial Adviser
€750 million
Extension of Credit Facilities
Right Arrow in Circle
July 2024
transaction logo image
Joint Bookrunner
€921 million
Accelerated Bookbuild Offering
Right Arrow in Circle
July 2024
transaction logo image
Sole Financial Adviser
€55 million
Minority investment in Payt 
Right Arrow in Circle
June 2024
zealand
Lead Manager
USD 1.0 billion
Accelerated Bookbuild Offering
Right Arrow in Circle
May 2024
merus
Lead Manager
USD 460 million
US Public Offering
Right Arrow in Circle
May 2024
Vesteda logo
Sole Financial Adviser
€90 million
Secondary transaction in Vesteda by MN on behalf of Bpf MITT
Right Arrow in Circle
April 2024
Argan logo
Joint Global Coordinator & Joint Bookrunner
€150 million
Accelerated Bookbuild Offering
Right Arrow in Circle
April 2024
Pharming logo
Sole Financial Adviser
New issue €100 million & repurchase €123 million
Convertible bond issue and repurchase
Right Arrow in Circle
April 2024
transaction logo image
Financial Adviser
SEK 107m
Rights Issue of Units
Right Arrow in Circle
March 2024
catena
Joint Global Coordinator & Joint Bookrunner
SEK 2,097 million
Accelerated Bookbuild Offering
Right Arrow in Circle
February 2024
transaction logo image
Sole Financial Adviser
Undisclosed
Sale to Visma
Right Arrow in Circle
February 2024
Autolus logo
Co-Manager
USD 350 million
US Offering
Right Arrow in Circle
January 2024
galapagos
Financial Adviser
€170 million
Sale of Jyseleca business to Alfasigma

Right Arrow in Circle
December 2023
zealand
Sole Financial Adviser
€90 million
Venture debt financing
Right Arrow in Circle
December 2023
transaction logo image
Sole Bookrunner
€51.8 million
Sale of shares
Right Arrow in Circle
November 2023
Amvest
Financial Adviser
€135 million
U.S. Private Placement
Right Arrow in Circle
December 2023
wdp
Joint Global Coordinator and Joint Bookrunner
€300 million
Accelerated Bookbuild Offering
Right Arrow in Circle
November 2023
montea Logo
Joint Global Coordinator & Joint Bookrunner
€126 million
Accelerated Bookbuild Offering
Right Arrow in Circle
October 2023
Cantargia logo
Joint Global Coordinator                            & Joint Bookrunner
SEK 59.3 million
Directed Share Issue
Right Arrow in Circle
October 2023
transaction logo image
Joint Global Coordinator                        & Joint Lead Bookrunner
NOK 505 million
Accelerated Bookbuild Offering
Right Arrow in Circle
October 2023
transaction logo image
Sole Financial Adviser
€260 million
Green Loan
Right Arrow in Circle
October 2023
synact pharma
Sole Financial Adviser
SEK 120 million
Structured Equity with Warrants
Right Arrow in Circle
October 2023
transaction logo image
Financial Adviser
Undisclosed
Acquisition of Novec GmbH
Right Arrow in Circle
October 2023
transaction logo image
Joint Bookrunner
€167 million
Accelerated Bookbuild Offering
Right Arrow in Circle
September 2023
DHG
Sole Financial Adviser
€625 million
Green Loan
Right Arrow in Circle
September 2023
transaction logo image
Adviser
€500 million
Proposed investment in Stedin Groep
Right Arrow in Circle
August 2023
merus
Lead manager
USD 173 million
Capital Increase
Right Arrow in Circle
July 2023
argenx
Manager
USD 1.3 billion
Capital Increase
Right Arrow in Circle
July 2023
nsi
Sole Financial Adviser
€65 million
Secured Term Loan Extension
Right Arrow in Circle
June 2023
RED company logo
Joint Venture
Undisclosed
Sole Financial Adviser
Right Arrow in Circle
June 2023
vicore pharma
Joint Bookrunner
SEK 500 million
Capital increase
Right Arrow in Circle
June 2023
transaction logo image
Financial Adviser
USD 182 million
Secondary sell-down
Right Arrow in Circle
May 2023
transaction logo image
Joint Global Coordinator & Joint Bookrunner
€25.0 million
Accelerated Bookbuild Offering
Right Arrow in Circle
May 2023
TINC logo
Sole Financial Adviser
Undisclosed
Joint Venture
Right Arrow in Circle
April 2023
terrapay
Financial Adviser
>USD 100 million
Series B funding round
Right Arrow in Circle
April 2023
sequana medical
Joint Global Coordinator & Joint Bookrunner
€ 15.8 million
Accelerated Bookbuild Offering
Right Arrow in Circle
April 2023
zealand
Lead Manager
DKK 1.5 billion
Accelerated Bookbuild Offering
Right Arrow in Circle
March 2023
transaction logo image
Sole Financial Adviser
€ 14 million
Series B funding round
Right Arrow in Circle
March 2023
transaction logo image
Financial Advisor, Capital Markets Advisor & Placement Agent
USD 220m
PIPE USD 91 million
Right Arrow in Circle
Feb 2023
curevac
Lead Manager
USD 250 million
US Public Offering
Right Arrow in Circle
Jan 2023
Powerfield logo
Sole Financial Adviser
circa € 500 million
Structured Equity and Senior Debt Financing
Right Arrow in Circle
Dec 2022
gensight
Sole Financial Adviser
€ 12.0 million
Convertible Note Issuance
Right Arrow in Circle
Dec 2022
hansa
Joint Global Coordinator & Joint Bookrunner
SEK 416 million
PIPE
Right Arrow in Circle
Dec 2022
nsi
Sole Financial Adviser
€50 million
Term Loan Extension
Right Arrow in Circle
Dec 2022
synact pharma
Joint Global Coordinator & Joint Bookrunner
SEK 80 million
Directed Share Issue via PIPE
Right Arrow in Circle
Dec 2022
synact pharma
Sole Financial Adviser
SEK 191 million
Acquisition of TXP Pharma
Right Arrow in Circle
Dec 2022
vicore pharma
Joint Bookrunner
SEK 200 million
Accelerated Bookbuild Offering
Right Arrow in Circle
Dec 2022
biovica
Joint Bookrunner
SEK 148 million
Guaranteed Rights Issue
Right Arrow in Circle
Dec 2022
catena
Joint Global Coordinator & Joint Bookrunner
SEK 1,642 million
Accelerated Bookbuild Offering
Right Arrow in Circle
Dec 2022
molecular partners
Sole Block Placing Agent
1.3 million shares
Block Trade in Molecular Partner Shares
Right Arrow in Circle
Nov 2022
gensight
Sole Financial Adviser
€ 35.0 million
Secures a credit facility from the European Investment Bank
Right Arrow in Circle

All transactions

See all transactions made throughout the years.
All transactions in 2024
All transactions in 2023
All transactions in 2022
All transactions in 2021
All transactions in 2020
All transactions in 2019
All transactions in 2018
All transactions in 2017
All transactions in 2016
All transactions in 2015
All transactions in 2014
All transactions in 2013